Cough Assist Devices Market
Number of pages: 100 | Report Format: PDF | Published date: February 14, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 188.3 million |
|
Revenue Forecast in 2030 |
US$ 370.0 million |
|
CAGR |
7.8% |
|
Base Year for Estimation |
2021 |
|
Forecast Year |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Product Type, End-User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global cough assist devices market was valued at US$ 188.3 million in 2021 and is expected to register a revenue CAGR of 7.8% to reach at US$ 370.0 million by 2030.
Cough Assist Devices Market Fundamentals
A cough assist device is a type of medical equipment that uses controlled positive pressure to help clear mucus or other secretions from the lungs of patients who have difficulty coughing. It is used to assist people with conditions such as neuromuscular disorders, spinal cord injuries (SCIs), and other medical conditions that can make it difficult to cough effectively. These cough assist devices deliver a controlled burst of air into the lungs, which helps to break up and remove mucus and other secretions.
There are two types of cough assist devices available, namely, manual and automatic devices. The device is typically used in conjunction with other treatments, such as chest physical therapy, to help improve lung function and prevent complications, such as pneumonia. It is important to consult a healthcare professional to determine the appropriate type and usage of a cough assist device for an individual patient.
[67567567]
Cough Assist Devices Market Dynamics
The market for cough assist devices is driven by several factors, including an increased prevalence of chronic respiratory diseases, a growing aging population, and advancements in technology. The increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, is expected to drive demand for cough assist devices. Besides, the rising burden of the patient population suffering from various neuromuscular illnesses is principally responsible for the rise in demand for cough assist devices. This is owing to patients’ inability to adequately discharge secretions as a result of neuromuscular illnesses weakening their muscles. For instance, according to information published by the National Organization for Rare Disorders (NORD) in 2021, 1.5 to 3 in 100,000 persons in North America and Europe acquire amyotrophic lateral sclerosis (ALS), a rare condition that affects a variety of muscles in the body. Additionally, there are about 250,000 cases of muscular dystrophy in the U.S. Other parts of the world are predicted to experience similar patterns. Because cough aid devices swiftly blow air into the lungs and pull it out to remove mucus and are useful in patients with an ineffective cough due to muscle weakness, an increase in neuromuscular disorders could potentially lead to an increase in demand for these devices. Additionally, respiratory muscles are impacted by SCIs in the mid-cervical vertebrae (C3, C4, and C5), which may potentially increase product consumption. For instance, according to information released by the Australian Government in 2021, there were expected to be 8.6 instances of persistent traumatic SCI among those aged 15 and older in Australia between the years 2017 and 2019. Aspire, a prominent national organization that supports spinal cord injury patients in the U.K., also states that in 2021, estimated 50,000 people in the U.K. were expected to be living with a spinal cord injury. As a result of increase in the population affected by spinal cord injury, the demand for cough aid devices is projected to increase in the next few years.
Respiratory muscles are impacted by SCIs in the mid-cervical vertebrae (C3, C4, and C5), which may potentially increase product consumption. For instance, according to information released by the Australian Government in 2021, there were expected to be 8.6 instances of persistent traumatic SCI among those aged 15 and older in Australia between the years 2017 and 2018. Aspire, a prominent national organization that supports spinal cord injury patients in the UK, also states that in 2021, there will be 50,000 people in the UK who will be living with a spinal cord injury. As a result, the population affected by spinal cord injury is predicted to lead to an increase in demand for cough aid devices.
However, these devices can be expensive, making them out of reach for many patients, particularly those without insurance coverage or with high-deductible plans. Additionally, the cost of replacement parts and ongoing maintenance can also add to the overall expense of owning a cough assist device. This can limit access to these devices for many patients and hinder the cough assist device market revenue growth.
Cough Assist Devices Market Ecosystem
The global cough assist device market has been analyzed from four perspectives: product type, end user, and region.
Cough Assist Devices Market by Product Type
[7546546]
By product type, the cough assist devices market can be segmented into automatic and manual cough assist devices.
Automatic cough assist devices are operated using a machine or an electronic device, typically with pre-set settings and a control panel for adjustments. These devices can be programmed to provide specific levels of pressure and/or flow and can be used for patients with a wide range of conditions, including COPD, cystic fibrosis, and SCIs. Manual cough assist devices, on the other hand, are operated manually by the patient or a caregiver. These devices typically include manual chest clappers, which use mechanical vibration to help clear mucus from the lungs, and mechanical vest systems, which use an inflatable vest to apply pressure to the chest and help the patient forcefully exhale. Manual devices are typically less expensive than automatic devices and may be more portable. However, they may not be as effective for patients with more severe conditions. In general, the choice between an automatic or manual cough assist device depends on the patient’s specific needs, including the severity of their condition and their mobility. The devices are used to help patients with a variety of lung conditions clear secretions and improve breathing.
Cough Assist Devices Market by End User
Based on the end user, the cough assist devices market can be segmented into hospitals and clinics, home care settings, and others.
Hospitals and clinics are major end users of cough assist devices, as these institutions typically purchase these devices for use in inpatient settings, such as intensive care units and respiratory therapy departments. These devices are used to help patients with a variety of lung conditions clear secretions and improve breathing. The use of cough assist devices in home care settings is also on the rise. As patients can receive treatment in the comfort of their own homes, it eliminates the need for frequent hospital visits and is becoming more cost-effective for patients. This trend is expected to continue as more patients prefer to receive treatment at home.
Cough Assist Devices Market by Region
Based on the region, the global cough assist devices market is segmented into North America, Europe, Asia Pacific, and the rest of the world.
In the upcoming years, North America is anticipated to account for a significant revenue share of the global market for cough assist devices. This dominance is due to the rising prevalence of numerous neuromuscular illnesses, SCIs, and other conditions that weaken and impair the muscles. Cough assist devices’ regional market expansion would also be aided by the existence of important manufacturers in the area and leading healthcare institutions. Additionally, 450,000 Americans are considered to be living with SCIs in the U.S., according to the American Association of Neurological Surgeons’ estimates for 2021. The source also states that the U.S. sees approximately 17,000 new SCI cases each year. A spinal column injury is the primary cause for most of them.
The cough assist devices market in Asia Pacific is anticipated to expand quickly during the forecast period. This can be attributed to the surge in healthcare infrastructure investment brought on by the expansion of healthcare access and economic growth in nations such as China and India, which has resulted in easier access to medical procedures and technologies such as cough aid gadgets.
Cough Assist Devices Market Competitive Landscape
The leading companies operating in the global cough assist devices market are:
Cough Assist Devices Market Strategic Developments
Mechanical insufflation-exsufflation devices, known as cough assist devices, are used to simulate a normal cough and non-invasively expel mucus from the lungs. The apparatus includes a mask, mouthpiece, or tracheostomy adaptor that is placed over the airway.
The increasing prevalence of different neuromuscular illnesses around the world is one of the main factors boosting revenue growth in cough assisted devices market. Moreover, the global market for cough assist devices is expected to be driven by the increase in the prevalence of SCIs, the advantages that devices have over manual cough help techniques, and an increase in new product approvals.
Koninklijke Philips N.V., Hill-Rom Services, Inc. (Baxter), Dima Italia Srl, United Hayek Industries Inc., and Ventec Life Systems are among the key players in the global market.
The global cough assists devices market is restricted by factors such as high cost, limited awareness, reimbursement issues, limited availability, lack of standardization, limited research and development, lack of regulatory approvals, and competition from other devices and therapies.
The global cough assist devices market is expected to register a revenue CAGR of 7.8% during the forecast period.
*Insights on financial performance are subject to the availability of information in the public domain